These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9627937)

  • 1. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
    Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
    Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants.
    Kaashoek MJ; van Engelenburg FA; Moerman A; Gielkens AL; Rijsewijk FA; van Oirschot JT
    Vet Microbiol; 1996 Jan; 48(1-2):143-53. PubMed ID: 8701570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of glycoproteins gC, gE, gI, and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1.
    Denis M; Hanon E; Rijsewijk FA; Kaashoek MJ; van Oirschot JT; Thiry E; Pastoret PP
    Vet Microbiol; 1996 Nov; 53(1-2):121-32. PubMed ID: 9011004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
    Schynts F; Lemaire M; Ros C; Belak S; Thiry E
    Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quadruple Gene-Deleted Live BoHV-1 Subunit RVFV Vaccine Vector Reactivates from Latency and Replicates in the TG Neurons of Calves but Is Not Transported to and Shed from Nasal Mucosa.
    Pavulraj S; Stout RW; Paulsen DB; Chowdhury SI
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments.
    Mars MH; de Jong MC; van Oirschot JT
    Vaccine; 2000 Apr; 18(19):1975-81. PubMed ID: 10706958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves.
    van Engelenburg FA; Kaashoek MJ; Rijsewijk FA; van den Burg L; Moerman A; Gielkens AL; van Oirschot JT
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2311-8. PubMed ID: 8077929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects.
    Kaashoek MJ; Straver PH; Van Rooij EM; Quak J; Van Oirschot JT
    Vet Rec; 1996 Oct; 139(17):416-21. PubMed ID: 8923716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
    Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
    Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
    Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
    Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
    Kalthoff D; König P; Trapp S; Beer M
    Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle.
    Muylkens B; Meurens F; Schynts F; Farnir F; Pourchet A; Bardiau M; Gogev S; Thiry J; Cuisenaire A; Vanderplasschen A; Thiry E
    J Gen Virol; 2006 Aug; 87(Pt 8):2149-2154. PubMed ID: 16847110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1.
    Khattar SK; Collins PL; Samal SK
    Vaccine; 2010 Apr; 28(18):3159-70. PubMed ID: 20189484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
    Muylkens B; Meurens F; Schynts F; de Fays K; Pourchet A; Thiry J; Vanderplasschen A; Antoine N; Thiry E
    Vet Microbiol; 2006 Mar; 113(3-4):283-91. PubMed ID: 16321480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on latency in calves by five vaccines against bovine herpesvirus-1 infection.
    Castrucci G; Frigeri F; Salvatori D; Ferrari M; Dico ML; Rotola A; Sardonini Q; Petrini S; Cassai E
    Comp Immunol Microbiol Infect Dis; 2002 Jul; 25(4):205-15. PubMed ID: 12135235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of latent bovine herpesvirus 1 in cattle seronegative to glycoproteins gB and gE.
    Hage JJ; Glas RD; Westra HH; Maris-Veldhuis MA; Van Oirschot JT; Rijsewijk FA
    Vet Microbiol; 1998 Feb; 60(2-4):87-98. PubMed ID: 9646441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
    Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
    Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.